Public Private Partnerships in trust-based public health social networking: Connecting organizations for regional disease surveillance (CORDS)
Journal of Commercial Biotechnology (2011) Volume 17
Co-authors: Leslie A Pray, Suwit Wibulpolprasert and Beverly Trayner
The article describes a new trust-based global health security initiative known as CORDS: Connecting Organizations for Regional Disease Surveillance. Initiated and managed by the Nuclear Threat Initiative with support of The Rockefeller Foundation, Fondation Mérieux and the Skoll Global Threats Fund. CORDS is a non-governmental platform to transform dialogue among public health, veterinary and wildlife professionals from multi-country infectious disease surveillance networks. It also links with the World Health Organization, World Organization for Animal Health and other global partners in managing cross-border emerging infectious disease threats and building disease surveillance capacity. The public–private partnerships of CORDS create a global social fabric and continuity of disease experts based upon trust.
Click here for access to the article through the publisher.
About
A journal article published in the Journal of Commercial Biotechnology (2011) Volume 17, describing a new trust-based global health security initiative known as CORDS: Connecting Organizations for Regional Disease Surveillance
Understanding
the Biological Threat
In Depth
Global Security Newswire
-
Most Nations Still Lack Required Disease Outbreak Response Capacity
Feb. 28, 2013
WASHINGTON -- A majority of nations have yet to fulfill a 6-year-old U.N. mandate to develop certain critical public health capacities to respond to naturally occurring or man-made disease outbreaks, according to a senior U.S. State Department official.
-
CDC Touts Advances in Lab Detection of WMD Threats
Sept. 21, 2011
The U.S. Centers for Disease Control and Prevention on Tuesday touted advancements made in local and state laboratories' capacities to identify dangerous biological and chemical materials, the Center for Infectious Disease Research and Policy reported (see GSN, Sept. 6).
